|
1 Company |
|
2 Products |
|
2 Products |
|
2 Mechanisms of Action |
|
0 Trials |
|
4 News |
|
- erlotinib / Generic mfg.
Trial completion: Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma (clinicaltrials.gov) - Jan 6, 2015
P2a, N=45, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed
- Trial completion: Phase II A Trial of Curcumin Among Patients With Prevalent Subclinical Neoplastic Lesions (Aberrant Crypt Foci) (clinicaltrials.gov) - Jul 31, 2013
P2, N=48, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- erlotinib / Generic mfg.
Enrollment closed: Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma (clinicaltrials.gov) - Jan 27, 2013
P2a, N=48, Active, not recruiting, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Recruiting --> Active, not recruiting